Navigation Links
AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program
Date:8/1/2014

NORTH CHICAGO, Ill. and PALO ALTO, Calif., Aug. 1, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Cystic Fibrosis Research, Inc. (CFRI) today announced a partnership to expand awareness of proper nutritional habits in the cystic fibrosis (CF) community through the CFChef Shares program. CFChef Shares will run from August 1 to September 15, 2014, as part of AbbVie's CFChef program – an online resource for CF patients and caregivers – to encourage patients to maintain a healthy diet by submitting recipes to the Chef4CF.com Online Cookbook. The program will begin at the CFRI 27th National Family Cystic Fibrosis Education Conference, on August 1-3, 2014, in Redwood City, Calif.

"CFChef has been a vital nutritional resource for patients and caregivers for years, and we are confident that the CFChef Shares program will continue to deliver the message that proper nutrition is extremely important for those living with CF," said Sue Landgraf, executive director, CFRI. "We are excited to partner with AbbVie, a company that is committed to the health and well-being of the CF community."

AbbVie is kicking off this partnership with a one-week call for recipes: AbbVie will donate an additional $5,000 if 50 recipes are submitted to the CFChef Shares website by August 8. The partnership will continue with additional donations of $10 to CFRI for each recipe submitted to the CFChef website during this six-week period, up to $10,000. CFRI will put the money raised during the donation period toward providing educational resources and support for increasing awareness among patients of the importance of maintaining a proper CF diet. The public has an opportunity to help donate an additional $2 per recipe by sharing any of the recipes in the Online Cookbook on social media. The Online Cookbook page can be accessed here: www.Chef4CF.com/recipes/.

"CFChef Shares aims to help CF patients find support, nutritional recipes and meal tips," said Jim Hynd, vice president, GI Care. "Over the last 20 years, AbbVie has demonstrated its commitment to supporting the unique needs of CF patients, and partnerships like this help to emphasize the importance of nutrition in this community."

Cystic fibrosis is an inherited chronic disease that affects the respiratory, reproductive and digestive systems of approximately 30,000 children and adults in the United States. More than 70 percent of people with CF are diagnosed by age two. Today, more than 45 percent of people living with CF are aged 18 or older.

In patients with CF, a thick, sticky mucus is produced in certain organs throughout the body, most commonly the lungs and digestive system, including the pancreas.  Many people living with CF are unable to properly digest food because of the thick mucus in the digestive system. Additionally, the pancreas does not produce enough digestive pancreatic enzymes in these patients, causing malabsorption of the calories and nutrients (vitamins and minerals) in food. To achieve proper nutrition, individuals with CF need to consume more calories than a person without the disease.

About CFChef
CFChef is an online nutrition website to help people living with cystic fibrosis (CF) and their families better understand the unique nutritional needs of people living with the disease. In addition to serving as an educational resource, CFChef aims to raise awareness of the importance of good nutritional habits and provide a place where families, friends and caregivers of people with CF can share recipes and get updated nutrition tips and guidance.  To learn more visit, CFChef at www.Chef4CF.com.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

About Cystic Fibrosis Research, Inc.
Cystic Fibrosis Research, Inc. (CFRI) is a 501(c)(3) nonprofit organization, founded in 1975. CFRI exists to fund research, to provide educational and personal support, and to spread awareness of cystic fibrosis, a life-threatening genetic disease.


'/>"/>
SOURCE AbbVie
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. AbbVie Named to S&P 500 Dividend Aristocrat Index
2. AbbVie Issues Inaugural Full-Year Outlook for 2013
3. AbbVie to Present at Barclays Global Health Care Conference
4. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
5. AbbVie to Host First-Quarter Earnings Conference Call
6. AbbVie Reports First-Quarter 2013 Financial Results
7. AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
8. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
9. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
10. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
11. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Markarian, DDS, are co-chairs for the Illinois State Dental Society (ISDS) Foundation’s Mission ... at the Gateway Convention Center in Collinsville. , They expect to ...
(Date:6/23/2016)... LAKEWOOD, Colo., USA (PRWEB) , ... June 23, ... ... company, and Sanquin Blood Supply Foundation, a not-for-profit organization responsible for clinical transfusion ... completion of patient enrollment for the Pathogen Reduction Evaluation and Predictive Analytical Rating ...
(Date:6/23/2016)... ... 23, 2016 , ... SyncDog, Inc. , the leading ... is featured in the current issue of Silicon Review magazine. Silicon ... technology solutions and features them in their magazine. The magazine allows top-level executives ...
(Date:6/23/2016)... NJ (PRWEB) , ... June 23, 2016 , ... ... today’s Appellate Court ruling a victory for consumers seeking relief from the crushing ... Docket No. A2913-15T2 & A2929-15T2. , In their ruling ( http://www.judiciary.state.nj.us/opinions/a2913-15a2929-15.pdf ...
(Date:6/23/2016)... Nationwide (PRWEB) , ... June 23, 2016 , ... A ... Washington DC area, which is one of the best known examples of areas that ... already amassed almost a thousand daily users. , Any participant within the marijuana ...
Breaking Medicine News(10 mins):